EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Serum fetuin-A is decreased in cirrhotic patients with Wilson’s disease

Krisztián Vörös iD, Bernadett Márkus, Klára Atzél, Ferenc Szalay, László Gráf, Dániel Németh, Tamás Masszi, Péter Torzsa, László Kalabay iD

PLOS ONE · 2023

DOI: 10.1371/journal.pone.0282801 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Krisztián Vörös und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Family Medicine, Semmelweis University, Budapest, Hungary. Hauptthemen laut MEDLINE: Hepatolenticular Degeneration. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hungarian Ministry of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Wilson’s disease may lead to cirrhosis, but timely medical treatment could slow down its progression. Clinical markers helping early diagnosis are essential. Decreased fetuin-A concentration has been reported in cirrhosis of different etiologies. The aim of this study was to investigate whether decreased serum fetuin-A concentration could identify patients with Wilson’s disease who developed cirrhosis. Materials and methods In this cross-sectional study we determined the serum fetuin-A concentration of 50 patients with Wilson’s disease. We analyzed the data of patients with liver involvement, comparing cirrhotic and non-cirrhotic patients.

Results

Among patients with liver involvement those with cirrhosis had significantly lower fetuin-A and albumin level, white blood cell and platelet count. Fetuin-A negatively correlated with disease duration, bilirubin level, positively with total protein and albumin concentration, but not with copper and ceruloplasmin concentrations or markers of systemic inflammation. In multivariate analysis with fetuin-A and the Nazer score or its parameters only fetuin-A was a significant determinant of having cirrhosis. In receiver operator curve analysis among patients with liver involvement the fetuin-A level of 523 μg/ml was associated with cirrhosis with 82% sensitivity and 87% specificity. The presence of the H1069Q mutation was not associated with alteration in fetuin-A concentration.

Conclusions

The serum concentration of fetuin-A is a sensitive marker of liver cirrhosis in Wilson’s disease, independently of the H1069Q mutation, ceruloplasmin concentration or systemic inflammation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatolenticular DegenerationHumansalpha-2-HS-GlycoproteinCeruloplasminCross-Sectional StudiesLiver Cirrhosisalpha-FetoproteinsInflammationAlbumins

Substanzen

alpha-2-HS-GlycoproteinCeruloplasminalpha-FetoproteinsAlbumins

Autor:innen und Institutionen

  • Department of Family Medicine, Semmelweis University, Budapest, Hungary.
  • Department of Internal Medicine and Oncology, Semmelweis University, Budapest, Hungary.
  • Department of Internal Medicine and Hematology, Semmelweis University, Budapest, Hungary.

ORCID-Profile: Krisztián Vörös, László Kalabay

Förderung

  • Hungarian Ministry of Health

Zitieren

APA

Vörös, K., Márkus, B., Atzél, K., Szalay, F., Gráf, L., Németh, D., Masszi, T., Torzsa, P., & Kalabay, L. (2023). Serum fetuin-A is decreased in cirrhotic patients with Wilson’s disease. PLOS ONE. https://doi.org/10.1371/journal.pone.0282801

Vancouver

Vörös K, Márkus B, Atzél K, Szalay F, Gráf L, Németh D, et al. Serum fetuin-A is decreased in cirrhotic patients with Wilson’s disease. PLOS ONE. 2023. doi:10.1371/journal.pone.0282801

BibTeX
@article{Vrs2023,
  author = {Vörös, Krisztián and Márkus, Bernadett and Atzél, Klára and Szalay, Ferenc and Gráf, László and Németh, Dániel and Masszi, Tamás and Torzsa, Péter and Kalabay, László},
  title = {Serum fetuin-A is decreased in cirrhotic patients with Wilson’s disease},
  journal = {PLOS ONE},
  year = {2023},
  doi = {10.1371/journal.pone.0282801}
}
Kostenlos starten →